Armand Van Deun

8.0k total citations · 2 hit papers
122 papers, 5.2k citations indexed

About

Armand Van Deun is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Armand Van Deun has authored 122 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Infectious Diseases, 98 papers in Epidemiology and 26 papers in Surgery. Recurrent topics in Armand Van Deun's work include Tuberculosis Research and Epidemiology (108 papers), Mycobacterium research and diagnosis (58 papers) and Pneumonia and Respiratory Infections (35 papers). Armand Van Deun is often cited by papers focused on Tuberculosis Research and Epidemiology (108 papers), Mycobacterium research and diagnosis (58 papers) and Pneumonia and Respiratory Infections (35 papers). Armand Van Deun collaborates with scholars based in Belgium, France and Bangladesh. Armand Van Deun's co-authors include Leen Rigouts, Bouke C. de Jong, Françoise Portaels, A Wright, K. J. M. Aung, Hans L. Rieder, Aung Kya Jai Maug, Paul Daru, Hans L. Rieder and Pankaj Das and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Armand Van Deun

120 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

2010 453 citations Armand Van Deun, Aung Kya Jai Maug et al. American Journal of Respiratory and Critical Care Medicine profile →
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

2019 222 citations Armand Van Deun, Gabriela Torrea et al. profile →

Peers

Armand Van Deun

EPIDE

SURGE

Matteo Zignol Switzerland

Elizabeth M. Streicher South Africa

Rosella Centis Italy

Neel R. Gandhi United States

Roxana Rustomjee South Africa

Rodney Dawson South Africa

Wing Wai Yew China

Bouke C. de Jong Belgium

Yanlin Zhao China

Helen McIlleron South Africa

Matteo Zignol Switzerland

Armand Van Deun

4.3k ×0.9

3.5k ×0.9

EPIDE

1.6k ×0.8

SURGE

790 ×1.2

292 ×0.9

Citations per year, relative to Armand Van Deun Armand Van Deun (= 1×) peers Matteo Zignol

Countries citing papers authored by Armand Van Deun

Since Specialization

Citations

This map shows the geographic impact of Armand Van Deun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armand Van Deun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armand Van Deun more than expected).

Fields of papers citing papers by Armand Van Deun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armand Van Deun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armand Van Deun. The network helps show where Armand Van Deun may publish in the future.

Co-authorship network of co-authors of Armand Van Deun

This figure shows the co-authorship network connecting the top 25 collaborators of Armand Van Deun. A scholar is included among the top collaborators of Armand Van Deun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armand Van Deun. Armand Van Deun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lempens, Pauline, Armand Van Deun, K. J. M. Aung, et al.. (2023). Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh. Microbial Genomics. 9(9).

Souleymane, Mahamadou Bassirou, Alberto Piubello, Achilleas Tsoumanis, et al.. (2023). High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin. International Journal of Infectious Diseases. 133. 78–81. 8 indexed citations

Souleymane, Mahamadou Bassirou, Tom Decroo, Saïdou Mamadou, et al.. (2022). Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study. International Health. 15(3). 258–264. 2 indexed citations

Lynen, Lutgarde, et al.. (2021). Pretomanid for tuberculosis: a systematic review. Clinical Microbiology and Infection. 28(1). 31–42. 50 indexed citations

Deun, Armand Van, Tom Decroo, Aung Kya Jai Maug, et al.. (2020). The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance. PLoS ONE. 15(5). e0233500–e0233500. 13 indexed citations

Souleymane, Mahamadou Bassirou, Alberto Piubello, Nimer Ortuño‐Gutiérrez, et al.. (2020). High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss. European Respiratory Journal. 57(1). 2002250–2002250. 12 indexed citations

Decroo, Tom, Aung Kya Jai Maug, M. Anwar Hossain, et al.. (2020). Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes. PLoS ONE. 15(8). e0238016–e0238016. 6 indexed citations

Torrea, Gabriela, Armand Van Deun, Emmanuel André, et al.. (2019). Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance. Scientific Reports. 9(1). 11826–11826. 33 indexed citations

Sander, Melissa, et al.. (2016). Sputum bacterial load predicts multidrug-resistant tuberculosis in retreatment patients: a case-control study. The International Journal of Tuberculosis and Lung Disease. 20(6). 793–799. 4 indexed citations

10.

Daneau, Géraldine, Mourad Gumusboga, Pim de Rijk, et al.. (2016). The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide. International Journal of Mycobacteriology. 5. S46–S47. 7 indexed citations

11.

Aung, K. J. M., et al.. (2014). Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients. The International Journal of Tuberculosis and Lung Disease. 18(10). 1180–1187. 227 indexed citations

12.

Aung, K. J. M., et al.. (2012). Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in rural Bangladesh: lessons learnt. Public Health Action. 2(3). 76–78. 2 indexed citations

13.

Deun, Armand Van & Hans L. Rieder. (2012). DOT, S, or DOTS? [Editorial]. Public Health Action. 2(1). 3–4. 5 indexed citations

14.

Kurbatova, Ekaterina V., Joseph S. Cavanaugh, N. Sarita Shah, et al.. (2012). Rifampicin-resistant <I>Mycobacterium tuberculosis</I>: susceptibility to isoniazid and other anti-tuberculosis drugs [Short communication]. The International Journal of Tuberculosis and Lung Disease. 16(3). 355–357. 29 indexed citations

15.

Deun, Armand Van, et al.. (2010). Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 182(5). 684–692. 453 indexed citations breakdown →

16.

Eyangoh, Sara, et al.. (2008). HIV-related incremental yield of bleach sputum concentration and fluorescence technique for the microscopic detection of tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases. 27(9). 849–855. 11 indexed citations

17.

Siddiqi, Kamran, James Newell, Patrick Van der Stuyft, et al.. (2007). Improving sputum microscopy services for the diagnosis of tuberculosis in Peru and Bolivia.. PubMed. 11(6). 665–70. 9 indexed citations

18.

Deun, Armand Van, Hans L. Rieder, Cheng‐Yang Chiang, et al.. (2005). Tuberculosis bacteriology, priorities and indications in high prevalence countries: position of the technical staff of the Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease. The International Journal of Tuberculosis and Lung Disease. 9(4). 355–361. 41 indexed citations

19.

Lambert, Marie‐Laurence, Epco Hasker, Armand Van Deun, et al.. (2003). Recurrence in tuberculosis: relapse or reinfection?. The Lancet Infectious Diseases. 3(5). 282–287. 157 indexed citations

20.

Deun, Armand Van, et al.. (2000). Bleach sedimentation method for increased sensitivity of sputum smear microscopy: does it work?. PubMed. 4(4). 371–6. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact